Loading…
Loading…
Pfizer's non-oncology portfolio faced mixed Q2 trends. Eliquis and Vyndaqel sales may have risen while COVID products will have declined.
In the latest trading session, Pfizer (PFE) closed at $24.75, marking a -1.2% move from the previous day.
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Dimensional Fund Advisors LP boosted its stake in Pfizer Inc. (NYSE: PFE) by 0.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 36,422,799 shares of the biopharmaceutical company's stock after purchasing an additional 293,029 shares during the quarter.
Pfizer has an attractive weight loss pipeline. However, it will be hard to take the lead from other companies in this fast-growing area.
Pfizer is deeply out of favor today, with a historically high dividend yield of 6.9%. The company is dealing with headwinds, but they are pretty normal, and Pfizer is addressing them.
Aviance Capital Partners LLC boosted its holdings in shares of Pfizer Inc. (NYSE: PFE) by 21.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 165,588 shares of the biopharmaceutical company's stock after buying an additional 29,219 shares during
I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates quality dividend opportunities from yield traps by analyzing dividend sustainability, growth prospects, and valuation. The article explores three dividend strategies, "High-Yield Defensive," "Balanced Income," and "Pure Growth," designed for goals ranging from high yield to dividend growth.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for PFE and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.